Article Details
Retrieved on: 2021-02-12 12:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche's anti-inflammatory drug tocilizumab, marketed as Actemra/RoActemra, has been found to reduce the risk of death in patients hospitalised with ...
Article found on: www.pmlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here